| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | President And CEO
3 companies
Swirsky Douglas J is a Chief Financial Officer at MXCT, with reported holdings spanning 3 companies. Recent filings cover 3 purchases and 2 sales. Those positions are worth an estimated $181K at current prices.
Our model assigns Swirsky Douglas J a below-average insider score of 44/100, based on 3 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +10.5%.
Swirsky Douglas J's largest disclosed position is in MXCT as Chief Financial Officer, worth about $124K. Net of sales, the recent Form 4 record there shows accumulation of 32,919 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | MXCT Maxcyte, Inc. | Chief Financial Officer | Sell | 10,142 | $0.82 | $8,265.73 | -6.3% | +45.0% | - | |
| Aug 13, 2025 | MXCT Maxcyte, Inc. | Chief Financial Officer | Buy | 50,000 | $1.29 | $64,500.00 | +44.7% | +12.3% | +0.7% | |
| Mar 18, 2025 | MXCT Maxcyte, Inc. | Chief Financial Officer | Sell | 6,939 | $3.18 | $22,061.16 | -5.8% | -29.8% | -77.1% | |
| Sep 14, 2021 | CLRB Cellectar Biosciences, Inc. | Director | Buy | 25,000 | $1.04 | $26,000.00 | New | -30.8% | -56.1% | |
| Jan 29, 2019 | IRD Opus Genetics, Inc. | President And CEO | Buy | 50,000 | $0.63 | $31,720.00 | New | - | - |